International Society on Thrombosis and Haemostasis (ISTH) 2025 Congress

International Society on Thrombosis and Haemostasis (ISTH) 2025 Congress is organized by International Society on Thrombosis and Haemostasis (ISTH) and will be held from Jun 21 - 25, 2025 at Walter E. Washington Convention Center, Washington, Dist of Col, United States of America.

Description:
The ISTH 2025 Congress is expected to be the premier gathering place for the world's experts in thrombosis and hemostasis. Join us in Washington, D.C., for this exciting convergence of groundbreaking research, important networking opportunities, and a chance to gain insights from global experts. Don't miss this chance to expand your professional horizons and stay at the forefront of cutting-edge developments!

At ISTH 2025, thousands of the world’s leading experts on thrombosis, hemostasis and vascular biology come together to present the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care.

Through an extensive lineup of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities, the Congress promotes important scientific discourse and advancement.

The ISTH 2025 Congress Program will feature:

• 4 Plenary sessions
• 28 State-of-the-Art sessions
• 80 Oral Communication sessions each featuring five presentations on the latest abstracts.
• 24 Scientific and Standardization Committee (SSC) subcommittee sessions
• 30 Master Classes and 12 Career Development sessions
• Poster sessions
• Supported symposia and presentation theaters
• Engaging industry exhibition
• New! Daily special sessions

Main Topics:

• Acquired and Critical Care Bleeding
• Antithrombotic and Fibrinolytic Therapies
• Arterial Disease
• Coagulation Factors and Cofactors
• Coagulation Modifiers, Anticoagulants, and von Willebrand Factor
• Diagnostics, OMICs, and Advanced Technologies
• Fibrinogen, Factor XIII, and Fibrinolysis
• Hemophilia and other Inherited Bleeding Disorders and Inhibitors
• Nurses and Allied Health
• Pediatric Hemostasis and Thrombosis
• Platelet Disorders
• Platelets and Megakaryocytes
• Vascular Biology, Blood Cells, and Immunothrombosis
• Venous Disease
• Women's Hemostasis and Thrombosis

Acquired and Critical Care Bleeding

• Antithrombotic Drug-Associated Bleeding
• Coagulopathy of Liver and Renal Disease
• Coagulopathy of Other Systemic Diseases
• Coagulopathy of Trauma
• Massive Transfusion Management
• Perioperative Bleeding

Antithrombotic and Fibrinolytic Therapies

• Current Anticoagulants
• Future Anticoagulants
• Current Antiplatelet Agents
• Future Antiplatelet Agents
• Current and Future Fibrinolytic Therapies
• Antithrombotic Stewardship

Arterial Disease

• Atrial Fibrillation
• Cerebrovascular Disease
• Coronary Artery and Other Cardiac Diseases
• Peripheral Artery Disease

Coagulation Factors and Cofactors

• Common Pathway
• Contact Pathway
• Non-hemostatic Roles of Coagulation Proteins
• Protein Structure and Function
• Synthesis and Biochemistry
• TF and TFPI Pathway

Coagulation Modifiers, Anticoagulants, and von Willebrand Factor

• ADAMTS13 and Other Proteases
• Antithrombin and Other Serpins
• Non-hemostatic Roles of Anticoagulant Proteins
• Protein C/S Pathway
• von Willebrand Factor

Diagnostics, OMICs, and Advanced Technologies

• Artificial Intelligence/Machine Learning
• Genomics and Transcriptomics
• Mathematical and Computational Models
• Novel Experimental Models of Hemostatic and Thrombotic Diseases
• Novel Clinical Laboratory Diagnostic Methods
• Proteomics, Metabolomics, and Lipidomics

Fibrinogen, Factor XIII, and Fibrinolysis

• Factor XIII and Other Transglutaminases
• Fibrinogen Structure and Function
• Fibrinolysis and Proteolysis

Hemophilia and other Inherited Bleeding Disorders and Inhibitors

• Acquired Factor Deficiencies
• Gene Therapy
• Congenital Hemophilia with Inhibitors
• Joint Health
• Novel Hemostatic Therapies
• Rare Factor Deficiencies
• Vascular Disorders
• Von Willebrand Disease

Nurses and Allied Health

• Nurses and Allied Health

Pediatric Hemostasis and Thrombosis

• Bleeding and Thrombotic Issues in Adolescence
• Neonatal Coagulation Disorders
• Pediatric Bleeding and Thrombosis
• Perioperative and Critical Care

Platelet Disorders

• Acquired Platelet Disorders
• Immune Thrombocytopenia - ITP, HIT, PF4 Antibodies
• Inherited Platelet Disorders
• Myeloproliferative Neoplasms and Clonal Disorders
• Thrombotic Microangiopathy

Platelets and Megakaryocytes

• Megakaryocyte Biology
• Non-hemostatic Roles of Platelets
• Platelet Biology
• Receptors and Signaling

Vascular Biology, Blood Cells, and Immunothrombosis

• Blood Vessel Structure and Function
• Coagulation and Cancer
• Coagulation and Non-Malignant Comorbidities
• Endothelial Cell Biology
• Extracellular Vesicles
• Infection and Immunity in Immunothrombosis and Bleeding
• Inflammation and Thrombosis
• Red Cell Disorders and Coagulation

Venous Disease

• Cancer-associated Thrombosis
• Deep and Superficial Venous Thrombosis
• Long-term Consequences of VTE - CTEPH, PTS, etc.
• Pulmonary Embolism
• Thrombophilia
• Unusual Site VTE

Women's Hemostasis and Thrombosis

• Hormonal Modulation of Coagulation
• Menstrual Bleeding Disorders
• Pregnancy
• Hormonal Modulation of Coagulation
• Menstrual Bleeding Disorders
• Pregnancy